Induction of Homosubtypic and Heterosubtypic Immunity to Influenza Viruses Using a Conserved Internal and External Proteins
- 16 May 2023
- journal article
- research article
- Published by Springer Nature in Current Microbiology
- Vol. 80 (6) , 1-11
Abstract
The immunogenicity and protective properties of the designed recombinant fusion peptide of 3M2e and truncated nucleoprotein (trNP), originating from Influenza A virus, were investigated in the BALB/c mice model in comparison with the Mix protein (3M2e + trNP). The results were evaluated by antibody response, cytokine production, lymphocyte proliferation assay, and mortality rate after challenge with homologous (H1N1) and heterologous (H3N2) influenza viruses in BALB/c mice. The animals that received the chimer protein with or without adjuvant had more specific antibody responses and elicited memory CD4 T cells, and cytokines of Th1 and Th2 cells compared to the Mix protein. Moreover, the Mix protein, like the recombinant chimer protein, provided equal and effective protection against both homologous and heterologous challenges in mice. Nevertheless, the chimer protein demonstrated superior immune protection compared to the Mix protein. The percentage of survived animals in the adjuvanted protein group (78.4%) was less than the non-adjuvanted one (85.7%). However, the Mix protein plus Alum could induce protective immunity in only 57.1% and 42.8% of homologous and heterologous virus-challenged mice, respectively. Regarding the sufficient immunogenicity and protectivity of the chimer protein construct against influenza viruses, the findings of the study suggest that the chimer protein without a requirement of adjuvant can be used as an adequate vaccine formulation to protect against a broad spectrum of influenza viruses.Keywords
This publication has 36 references indexed in Scilit:
- Correlates of protection against influenza infection in humans — on the path to a universal vaccine?Current Opinion in Immunology, 2013
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodesVaccine, 2011
- Vaccination with Different M2e Epitope Densities Confers Partial Protection against H5N1 Influenza A Virus Challenge in ChickensIntervirology, 2011
- Protection against multiple influenza A virus subtypes by intranasal administration of recombinant nucleoproteinArchives of Virology, 2010
- Research and development of universal influenza vaccinesMicrobes and Infection, 2010
- Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protectionVaccine, 2008
- Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1Emerging Infectious Diseases, 2007
- Vaccine adjuvants: Current state and future trendsImmunology & Cell Biology, 2004
- Role of Interleukin-4 (IL-4), IL-12, and Gamma Interferon in Primary and Vaccine-Primed Immune Responses to Friend Retrovirus InfectionJournal of Virology, 2001
- Purified Influenza Virus Nucleoprotein Protects Mice from Lethal InfectionJournal of General Virology, 1987